Author:
Bauer Michael,Gitlin Michael
Publisher
Springer International Publishing
Reference40 articles.
1. Baethge C, Simhandl C. Lithium in schizoaffective disorder and schizophrenia. In: Bauer M, Grof P, Müller-Oerlinghausen B, editors. Lithium in neuropsychiatry – the comprehensive guide. Abingdon: Informa Healthcare; 2006. p. 129–44.
2. Ballanger F, Tenaud I, Volteau C, Khammari A, Dréno B. Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis. Arch Dermatol Res. 2008;300:215–23.
3. Bauer M, Alda M, Priller J, Young LT, International Group For The Study Of Lithium Treated Patients (IGSLI). Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry. 2003;36 Suppl 3:S250–4.
4. Boccetta A, Loviselli A. Review: lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Mental Health. 2006;2:1–5.
5. Bschor T, Lewitzka U, Adli M. The use of lithium in non-psychiatric conditions. In: Bauer M, Grof P, Müller-Oerlinghausen B, editors. Lithium in neuropsychiatry – the comprehensive guide. Abingdon: Informa Healthcare; 2006. p. 237–50.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lithium: how low can you go?;International Journal of Bipolar Disorders;2024-01-30